Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
127.00
-0.80 (-0.63%)
At close: Sep 26, 2025, 3:59 PM
127.00
0.00%
After-hours: Sep 26, 2025, 05:59 PM EDT
Jazz Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.19B | 1.86B | 2.41B | 2.22B | 1.36B | 1.44B | 1.51B | 1.34B | 1.28B | 1.17B | 881.48M | 839.36M | 711.26M | 490.83M | 591.45M | 671.78M | 891.4M | 2.1B |
Short-Term Investments | 480M | 710M | 580M | 400M | 625M | 375M | 120M | 250M | 80M | n/a | n/a | 60M | 60M | n/a | n/a | n/a | n/a | 335M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 129.79M | 125.52M | 123.97M | 79.63M | 77.16M | 76.56M | 73.94M | 83.25M | 73.84M | 72.64M | 64.39M | 45.1M | 45.26M | 46.84M | 52.84M | 58.5M | 60.49M | 35.08M |
Receivables | 714M | 652.99M | 716.76M | 723.64M | 698.04M | 707.1M | 705.79M | 627.84M | 610.39M | 623.94M | 651.49M | 601.18M | 594.03M | 572.39M | 563.36M | 499.02M | 506.66M | 413.98M |
Inventory | 504.99M | 492.78M | 480.44M | 539.3M | 542.55M | 577.32M | 597.04M | 611.83M | 657.21M | 674.78M | 714.06M | 728.07M | 861.71M | 985.45M | 1.07B | 1.14B | 1.25B | 115.47M |
Other Current Assets | 297.56M | 259.82M | 261.54M | 354.21M | 325.85M | 314.54M | 320.81M | 310.4M | 272.46M | 245.24M | 267.19M | 250.02M | 255.53M | 334.78M | 252.39M | 225.1M | 200.19M | 147.73M |
Total Current Assets | 3.35B | 4.13B | 4.63B | 4.39B | 3.68B | 3.54B | 3.44B | 3.25B | 3.01B | 2.78B | 2.61B | 2.57B | 2.59B | 2.5B | 2.61B | 2.63B | 2.95B | 3.17B |
Property-Plant & Equipment | 248.06M | 228.05M | 227M | 253.59M | 242.43M | 227.87M | 234.99M | 287.51M | 298.3M | 303.09M | 301.38M | 290.07M | 317.89M | 341.04M | 343.42M | 344.63M | 426.32M | 249.6M |
Goodwill & Intangibles | 6.61B | 6.48B | 6.47B | 6.95B | 6.82B | 6.97B | 7.17B | 7.12B | 7.45B | 7.49B | 7.49B | 7.16B | 7.93B | 8.57B | 8.98B | 9.13B | 9.48B | 3.05B |
Total Long-Term Assets | 7.59B | 7.41B | 7.38B | 7.87B | 7.68B | 7.79B | 7.96B | 7.96B | 8.25B | 8.26B | 8.23B | 7.81B | 8.61B | 9.27B | 9.69B | 9.85B | 10.26B | 3.59B |
Total Assets | 10.94B | 11.53B | 12.01B | 12.26B | 11.36B | 11.33B | 11.39B | 11.2B | 11.26B | 11.05B | 10.84B | 10.38B | 11.2B | 11.77B | 12.3B | 12.48B | 13.21B | 6.76B |
Account Payables | 89.37M | 95.93M | 77.87M | 85.42M | 97.1M | 80.98M | 102.75M | 109.85M | 98.43M | 125.45M | 90.76M | 102.25M | 74.16M | 73.34M | 100.3M | 63.81M | 64.83M | 77.74M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 4K | 4K | 463K | 871K | 1.28M | 1.69M | 2.09M | 2.27M | 2.44M | 2.37M |
Short-Term Debt | 1.03B | 31M | 31M | 31M | 605.8M | 605.38M | 604.95M | 604.51M | 31M | 31M | 31M | 31M | 31M | 31M | 31M | 31M | 248.59M | 248.61M |
Other Current Liabilities | 135.74M | 167.52M | 189.76M | 150.61M | 110.85M | 141.46M | 142.32M | 144M | 103.83M | 134.35M | 169.41M | 212.43M | 137.39M | 153.65M | 193.1M | 202.84M | 160.93M | 114.11M |
Total Current Liabilities | 2.07B | 1.22B | 1.04B | 1.03B | 1.56B | 1.56B | 1.54B | 1.57B | 945.26M | 908.9M | 933.19M | 812.95M | 705.44M | 737.41M | 809.3M | 735.05M | 880.59M | 752.09M |
Long-Term Debt | 4.34B | 5.34B | 6.08B | 6.08B | 5.1B | 5.11B | 5.11B | 5.11B | 5.69B | 5.69B | 5.69B | 5.7B | 5.99B | 5.99B | 6.02B | 6.25B | 6.49B | 1.85B |
Other Long-Term Liabilities | 93.73M | 91.12M | 86.61M | 110.97M | 99.42M | 97.42M | 104.75M | 127.48M | 126.68M | 109.18M | 106.81M | 123.94M | 129.42M | 124.64M | 117M | 137.81M | 132.51M | 105.87M |
Total Long-Term Liabilities | 5.17B | 6.14B | 6.88B | 7.05B | 6.04B | 6.07B | 6.12B | 6.14B | 6.79B | 6.8B | 6.82B | 6.83B | 7.29B | 7.42B | 7.52B | 7.8B | 8.2B | 2.21B |
Total Liabilities | 7.24B | 7.36B | 7.92B | 8.08B | 7.6B | 7.63B | 7.66B | 7.71B | 7.73B | 7.71B | 7.75B | 7.64B | 8B | 8.16B | 8.33B | 8.54B | 9.08B | 2.96B |
Total Debt | 5.43B | 5.42B | 6.16B | 6.2B | 5.79B | 5.79B | 5.79B | 5.79B | 5.8B | 5.81B | 5.81B | 5.81B | 6.11B | 6.12B | 6.15B | 6.38B | 6.92B | 2.25B |
Book Value | 3.71B | 4.17B | 4.09B | 4.17B | 3.76B | 3.7B | 3.74B | 3.49B | 3.53B | 3.34B | 3.09B | 2.75B | 3.2B | 3.61B | 3.97B | 3.94B | 4.13B | 3.8B |
Book Value Per Share | 60.57 | 68.46 | 67.62 | 67.92 | 59.84 | 59.11 | 59.72 | 55.29 | 55.10 | 52.53 | 48.94 | 43.72 | 51.26 | 58.33 | 64.47 | 64.27 | 69.50 | 67.25 |
Common Stock | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K |
Retained Earnings | 191.31M | 1.03B | 1.13B | 936.23M | 871.18M | 864.04M | 878.66M | 884.3M | 811.85M | 803.01M | 733.59M | 974.31M | 993.96M | 959.35M | 830.23M | 865.58M | 918.41M | 1.28B |
Comprehensive Income | -485.77M | -785.61M | -947.67M | -603.4M | -888.23M | -882.39M | -842.15M | -1.04B | -866.82M | -980.23M | -1.13B | -1.62B | -1.11B | -590.72M | -400.36M | -397.52M | -190.94M | -179.43M |
Shareholders Equity | 3.71B | 4.17B | 4.09B | 4.17B | 3.76B | 3.7B | 3.74B | 3.49B | 3.53B | 3.34B | 3.09B | 2.75B | 3.2B | 3.61B | 3.97B | 3.94B | 4.13B | 3.8B |
Total Investments | 480M | 710M | 580M | 400M | 625M | 375M | 120M | 250M | 80M | n/a | n/a | 60M | 60M | n/a | n/a | n/a | n/a | 335M |